Vizimpro
Brand Name: Vizimpro
Generic Name: Dacomitinib (as monohydrate)
Active
Registration Number
DR-XY48710
Dosage Form
Film-Coated Tablet
Issuance Date
February 13, 2024
Expiry Date
April 25, 2028
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength30 mg
PackagingAlu-PA/Alu/PVC foil blister pack x 10's (Box of 30's)
Alu-PA/Alu/PVC foil blister pack x 10's (Box of 10's) as Physician's Samples
Classification
C
Classification
Prescription Drug (RX)
P
Pharmacologic
Antineoplastic Agent (Epidermal Growth Factor Receptor (EGFR) Tyrosine kinase Inhibitor)
A
Application
Monitored Release (MR) (Corrections)
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
Dacomitinib (as monohydrate)Active
Monograph: dacomitinib (as monohydrate)